gsk glp-1 Support Homepage The GLP-1 Revolution: From Diabetes

That's roughly 23% more weight loss than tirzepatide (Mounjaro/Zepbound) and 9% more than semaglutide (Ozempic/Wegovy) at their respective maximum doses

This involves swelling beneath the surface of the skin, often in the face, lips, or throat

Whyte said research was now looking at how to minimise weight-regain, noting that as well as maintaining muscle mass and making lifestyle changes, research suggested tapering down doses might help

2017 Wong CH, Siah KW, Lo AW

GLP-1 medications may help some women with PMOS, especially when insulin resistance, higher weight, prediabetes, type 2 diabetes, or cardiometabolic risk are present

Selected Research References Wilding JPH, et al